| |
| |
|
| Insider
Information: |
Nichols Garrett |
| Relationship: |
Chief Medical Officer |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
395,192 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$247,817 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
395,192 |
|
|
| Total
Value |
$247,817 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 133.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chimerix Inc |
CMRX |
Chief Medical Officer |
2020-02-10 |
260,066 |
2016-05-09 |
0 |
Premium* |
|
|
Candel Therapeutics, Inc. |
CADL |
Chief Medical Officer |
2023-11-28 |
135,126 |
2022-11-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADL |
Candel Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-11-28 |
4 |
D |
$0.90 |
$10,958 |
D/D |
(12,175) |
135,126 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2023-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
88,822 |
147,301 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
58,479 |
58,479 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2020-02-10 |
4 |
S |
$1.68 |
$14,830 |
D/D |
(8,805) |
260,066 |
0 |
% |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2020-02-07 |
4 |
S |
$1.70 |
$4,335 |
D/D |
(2,550) |
268,871 |
0 |
% |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2020-01-07 |
4 |
S |
$2.15 |
$66,045 |
D/D |
(30,680) |
271,421 |
0 |
% |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2019-07-25 |
4 |
D |
$3.49 |
$26,634 |
D/D |
(7,625) |
300,056 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2019-05-21 |
4 |
D |
$3.47 |
$16,270 |
D/D |
(4,695) |
307,681 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
312,376 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2019-01-29 |
4 |
D |
$2.20 |
$6,821 |
D/D |
(3,095) |
212,376 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
215,471 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2018-05-14 |
4 |
D |
$4.66 |
$26,490 |
D/D |
(5,680) |
90,471 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2018-02-02 |
4 |
D |
$4.67 |
$10,872 |
D/D |
(2,330) |
96,151 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2017-05-12 |
4 |
D |
$4.68 |
$59,464 |
D/D |
(12,712) |
98,481 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2017-03-10 |
4 |
A |
$4.10 |
$2,405 |
D/D |
587 |
111,193 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2017-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
30,375 |
110,606 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2016-09-09 |
4 |
A |
$4.05 |
$14,442 |
D/D |
3,566 |
80,231 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Medical Officer |
• – – |
2016-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
76,665 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
